Suppr超能文献

原发肿瘤和患者因素对结直肠癌肝转移患者根治性切除和治疗后生存的影响。

Influence of primary tumour and patient factors on survival in patients undergoing curative resection and treatment for liver metastases from colorectal cancer.

机构信息

Department of Surgery, Institute of Clinical Sciences, University of Gothenburg, Gothenburg, Sweden.

Department of Surgery, Helsingborg Hospital, Helsingborg, Sweden.

出版信息

BJS Open. 2020 Feb;4(1):118-132. doi: 10.1002/bjs5.50237. Epub 2019 Dec 2.

Abstract

BACKGROUND

Resection of the primary tumour is a prerequisite for cure in patients with colorectal cancer, but hepatic metastasectomy has been used increasingly with curative intent. This national registry study examined prognostic factors for radically treated primary tumours, including the subgroup of patients undergoing liver metastasectomy.

METHODS

Patients who had radical resection of primary colorectal cancer in 2009-2013 were identified in a population-based Swedish colorectal registry and cross-checked in a registry of liver tumours. Data on primary tumour and patient characteristics were extracted and prognostic impact was analysed.

RESULTS

Radical resection was registered in 20 853 patients; in 38·7 per cent of those registered with liver metastases, surgery or ablation was performed. The age-standardized relative 5-year survival rate after radical resection of colorectal cancer was 80·9 (95 per cent c.i. 80·2 to 81·6) per cent, and the rate after surgery for colorectal liver metastases was 49·6 (46·0 to 53·2) per cent. Multivariable analysis identified lymph node status, multiple sites of metastasis, high ASA grade and postoperative complications after resection of the primary tumour as strong risk factors after primary resection and following subsequent liver resection or ablation. Age, sex and primary tumour location had no prognostic impact on mortality after liver resection.

CONCLUSION

Lymph node status and complications have a negative impact on outcome after both primary resection and liver surgery. Older age and female sex were underrepresented in the liver surgical cohort, but these factors did not influence prognosis significantly.

摘要

背景

在结直肠癌患者中,切除原发肿瘤是治愈的前提条件,但越来越多地采用肝转移灶切除术以达到治愈目的。本项全国性登记研究考察了可根治性治疗原发肿瘤的预后因素,包括接受肝转移灶切除术的患者亚组。

方法

在一项基于人群的瑞典结直肠登记处中确定了 2009-2013 年接受结直肠原发肿瘤根治性切除术的患者,并在肝脏肿瘤登记处中进行交叉核对。提取原发肿瘤和患者特征数据,并分析其预后影响。

结果

共登记了 20853 例接受根治性结直肠切除术的患者;在登记的肝转移患者中,有 38.7%的患者接受了手术或消融治疗。根治性结直肠癌切除术后的年龄标准化 5 年相对生存率为 80.9%(95%可信区间 80.2%至 81.6%),结直肠肝转移灶手术后的生存率为 49.6%(46.0%至 53.2%)。多变量分析发现,淋巴结状态、多发转移部位、ASA 高分级和原发肿瘤切除术后的术后并发症是原发肿瘤切除和随后的肝切除或消融后的强危险因素。年龄、性别和原发肿瘤部位对肝切除术后的死亡率无预后影响。

结论

淋巴结状态和并发症对原发肿瘤切除和肝手术的结果均有负面影响。在肝手术组中,年龄较大和女性患者代表性不足,但这些因素对预后无显著影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99ab/6996641/963a5840b738/BJS5-4-118-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验